Published in JAMA Network Open · View the paper (DOI)
Admissions to drug treatment programs declined by nearly one-quarter in the US during the first year of the COVID-19 pandemic, with significant declines observed among people of color. The study suggests that this trend may be linked to the recent surge in drug overdose deaths.
Coverage from 2 institutions